APA (7th ed.) Citation

MK, L., EJ, D., C, C., AM, H., AM, E., IA, C., . . . AF, L. (2017). Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development? Frontiers in neurology, 8, 91. https://doi.org/10.3389/fneur.2017.00091

Chicago Style (17th ed.) Citation

MK, Leuchter, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, and Leuchter AF. "Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?" Frontiers in Neurology 8 (2017): 91. https://doi.org/10.3389/fneur.2017.00091.

MLA (9th ed.) Citation

MK, Leuchter, et al. "Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?" Frontiers in Neurology, vol. 8, 2017, p. 91, https://doi.org/10.3389/fneur.2017.00091.